Moderna (MRNA) Confirms FDA Authorization of Booster Dose of its COVID-19 Vaccine in the U.S.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
CDC Advisory Committee Recommends Booster Shot of Moderna's (MRNA) COVID-19 Vaccine
October 22, 2021 5:40 AM EDTModerna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the U.S. Centers for... More
U.S. FDA clears Moderna, J&J COVID-19 boosters, backs use of different vaccine for boost
October 20, 2021 5:02 PM EDTBy Ankur Banerjee and Michael Erman
(Reuters) -The U.S. Food and Drug Administration on Wednesday authorized booster doses of the COVID-19 vaccines from Moderna Inc and Johnson & Johnson, and said Americans can choose a different shot from their original inoculation as a booster.
That means all three vaccines authorized in the United States can also be given as boosters to some groups.
"The availability of these authorized boosters is important for continued protection against COVID-19 disease," acting FDA Commissioner Janet Woodcock said in a statement. She noted that data suggests vaccine effectiveness may wane... More
Moderna (MRNA), J&J (JNJ) Vaccine Booster EUAs Approved by FDA, Along with "Mix and Match" Booster Doses
October 20, 2021 4:50 PM EDTToday, the U.S. Food and Drug Administration took action to expand the use of a booster dose for COVID-19 vaccines in eligible populations. The agency is amending the emergency use authorizations (EUA) for COVID-19 vaccines to allow for the use of a single booster dose as follows:
The use of a single booster dose of the Moderna (NASDAQ: MRNA) COVID-19 Vaccine that may be administered at least 6 months after completion of the primary series to individuals:
65 years of age and older18 through 64 years of age at high risk of... More